Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting
{{output}}
Background: The measures used to assess Parkinson's disease (PD) in clinical trials were developed for a broad spectrum of disease severity, limiting their ability to detect meaningful changes in early PD over a feasible study p... ...
